Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FFGBJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,881
Award facts
- Contract value 100% obligated
- $10,880.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors, with a contract ceiling value of $10,880.69. This firm fixed-price delivery order was competitively awarded without set-aside provisions and carries an ultimate completion date of November 4, 2025. The award was issued on November 3, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat moderate-to-severe eczema, asthma, and other allergic inflammatory conditions, making it a critical pharmaceutical asset for military and federal healthcare systems.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. The company's competitive award of this delivery order reflects its established capability to meet federal medical procurement standards and its strategic role within the DLA's pharmaceutical supply chain for military healthcare programs.
Quick answers
Who was awarded contract SPE2DB26FFGBJ?
SPE2DB26FFGBJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FFGBJ worth?
The government has obligated $10,881 on SPE2DB26FFGBJ.
Is contract SPE2DB26FFGBJ an order under another contract?
Yes. SPE2DB26FFGBJ is a delivery order under SPE2DB24D3013, an indefinite delivery contract.
Was contract SPE2DB26FFGBJ competed?
The extent of competition for SPE2DB26FFGBJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award